T3	Effect 0 34	Temporary neurologic abnormalities
T4	Subject 52 74	one out of 23 patients
T5	Treat-Disorder 140 158	osteogenic sarcoma
T6	Treatment 86 135	chemotherapy with high-dose methotrexate (HD-MTX)
T8	Population 52 65	one out of 23
T9	Severity_cue 0 9	Temporary
T10	Route 86 98	chemotherapy
T11	Dosage 104 113	high-dose
T12	Drug 114 126	methotrexate
T7	Adverse_event 40 48	observed
E1	Adverse_event:T7 
A1	Severity E1 Low